Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19175905 | RECURSIVE TRANSFORMERS FOR AI-BASED PROTEIN-PROTEIN INTERACTION AND DRUG DESIGN | April 2025 | August 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 18733681 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | June 2024 | September 2025 | Allow | 15 | 2 | 0 | No | No |
| 18613558 | SELECTION OF A CHEMICAL COMPOUND APPLICABLE ON A CLASS OF HUMAN HAIRS | March 2024 | August 2025 | Allow | 17 | 2 | 0 | Yes | No |
| 18276808 | NEW DRUG CANDIDATE DISCOVERY SYSTEM AND COMPUTER PROGRAM IMPLEMENTING NEW DRUG CANDIDATE DISCOVERY PLATFORM | August 2023 | November 2025 | Abandon | 28 | 2 | 0 | Yes | No |
| 17845682 | AGILE NUCLEIC ACID SENSOR AND MEASURING A BIOMARKER | June 2022 | March 2026 | Allow | 44 | 1 | 1 | No | No |
| 17520621 | METHODS AND APPARATUS FOR PREDICTING WHETHER AND WHEN A HYPO/HYPER ANALYTE CONCENTRATION EVENT WILL OCCUR | November 2021 | November 2025 | Abandon | 48 | 3 | 2 | Yes | No |
| 17310158 | GROWTH INFORMATION MANAGEMENT APPARATUS, GROWTH INFORMATION MANAGEMENT SYSTEM, METHOD FOR CONTROLLING GROWTH INFORMATION MANAGEMENT APPARATUS, AND GROWTH INFORMATION MANAGEMENT PROGRAM | July 2021 | June 2025 | Abandon | 47 | 1 | 0 | No | No |
| 17296271 | INFORMATION PROCESSING APPARATUS, COSMETIC GENERATOR, AND COMPUTER PROGRAM | May 2021 | January 2026 | Abandon | 56 | 2 | 0 | No | No |
| 17286784 | USE OF MUCOSAL TRANSCRIPTOMES FOR ASSESSING SEVERITY OF ULCERATIVE COLITIS AND RESPONSIVENESS TO TREATMENT | April 2021 | October 2025 | Abandon | 54 | 2 | 0 | No | No |
| 17226813 | CONVERSION OF LONG CELL DATA TO SHORT CELL EQUIVALENT | April 2021 | December 2025 | Allow | 56 | 2 | 1 | Yes | No |
| 17279506 | Biological Information Analysis Apparatus, Biological Information Analysis Method, and Biological Information Analysis System | March 2021 | July 2025 | Abandon | 51 | 2 | 0 | No | No |
| 17209464 | Method and Apparatus for Performing Similarity Searching | March 2021 | December 2024 | Abandon | 45 | 1 | 0 | No | No |
| 17276020 | SYSTEM AND METHOD FOR PREDICTING QUALITY OF A CHEMICAL COMPOUND AND/OR OF A FORMULATION THEREOF AS A PRODUCT OF A PRODUCTION PROCESS | March 2021 | February 2025 | Abandon | 47 | 1 | 0 | No | No |
| 17186033 | STRUCTURE SEARCH METHOD, STRUCTURE SEARCH APPARATUS, AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM FOR STORING STRUCTURE SEARCH PROGRAM | February 2021 | May 2025 | Abandon | 50 | 1 | 0 | No | No |
| 17152591 | METHODS AND SYSTEMS FOR TREATING CANCER AND PREDICTING AND OPTIMIZING TREATMENT OUTCOMES IN INDIVIDUAL CANCER PATIENTS | January 2021 | February 2025 | Abandon | 49 | 1 | 0 | No | No |
| 17148589 | DEEP LEARNING-BASED METHOD FOR PREDICTING BINDING AFFINITY BETWEEN HUMAN LEUKOCYTE ANTIGENS AND PEPTIDES | January 2021 | June 2025 | Abandon | 53 | 2 | 0 | Yes | No |
| 17141259 | METHOD OF DETERMINING COLLECTIVE COORDINATE, INFORMATION PROCESSING DEVICE, AND COMPUTER-READABLE RECORDING MEDIUM RECORDING PROGRAM | January 2021 | October 2024 | Abandon | 45 | 1 | 0 | No | No |
| 17139302 | METHOD AND APPARATUS FOR NEW DRUG CANDIDATE DISCOVERY | December 2020 | October 2025 | Abandon | 57 | 2 | 0 | No | No |
| 17138053 | Memory Allocation to Optimize Computer Operations of Seeding for Burrows Wheeler Alignment | December 2020 | April 2025 | Allow | 51 | 2 | 0 | Yes | No |
| 17135676 | NON-INVASIVE DETECTION OF TISSUE ABNORMALITY USING METHYLATION | December 2020 | September 2025 | Allow | 56 | 1 | 1 | Yes | No |
| 17122397 | MOLECULAR TESTING OF MULTIPLE PREGNANCIES | December 2020 | November 2025 | Abandon | 59 | 2 | 1 | Yes | No |
| 17118447 | GENERATIVE MACHINE LEARNING MODELS FOR PREDICTING FUNCTIONAL PROTEIN SEQUENCES | December 2020 | November 2024 | Abandon | 47 | 1 | 1 | No | No |
| 17110287 | METHOD AND SYSTEM FOR NETWORK DATA COLLECTION, ANALYSIS, CONTROL, AND SELF-OPTIMIZATION OF A CLOSED ECOLOGICAL SYSTEM | December 2020 | January 2026 | Abandon | 60 | 2 | 1 | No | No |
| 16952847 | METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS | November 2020 | October 2024 | Allow | 47 | 1 | 0 | Yes | No |
| 17092194 | MICROSATELLITE INSTABILITY MEASUREMENT | November 2020 | June 2025 | Abandon | 56 | 6 | 1 | Yes | No |
| 17053606 | Control Of Nematodes | November 2020 | April 2025 | Allow | 54 | 2 | 1 | No | No |
| 17032106 | BLOOD TEST SUPPORT DEVICE, BLOOD TEST SUPPORT SYSTEM, BLOOD TEST SUPPORT METHOD, AND PROGRAM | September 2020 | February 2026 | Abandon | 60 | 3 | 0 | Yes | No |
| 17017458 | MONITORING DEVICE, PLANT GROWTH MONITORING METHOD USING MONITORING DEVICE, AND PLANT FACTORY | September 2020 | April 2025 | Abandon | 56 | 2 | 0 | No | No |
| 16967961 | CONCENTRATION BOUNDS IN LARGE NETWORKS | August 2020 | May 2025 | Abandon | 58 | 1 | 0 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner SABOUR, GHAZAL works in Art Unit 1686 and has examined 24 patent applications in our dataset. With an allowance rate of 20.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 54 months.
Examiner SABOUR, GHAZAL's allowance rate of 20.8% places them in the 2% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SABOUR, GHAZAL receive 1.83 office actions before reaching final disposition. This places the examiner in the 42% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by SABOUR, GHAZAL is 54 months. This places the examiner in the 2% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +37.8% benefit to allowance rate for applications examined by SABOUR, GHAZAL. This interview benefit is in the 85% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 20.0% of applications are subsequently allowed. This success rate is in the 21% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 16.7% of cases where such amendments are filed. This entry rate is in the 18% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 98% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.